We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$51.7M
Cap. Flow %
-14.57%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Consumer Discretionary 9.4%
3 Healthcare 9.16%
4 Industrials 8.21%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNX icon
101
TD Synnex
SNX
$19.9B
$945K 0.27%
+9,161
New +$974K
DGX icon
102
Quest Diagnostics
DGX
$26B
$930K 0.26%
6,799
+1,019
+18% +$142K
BKR icon
103
Baker Hughes
BKR
$58.3B
$908K 0.26%
24,950
+12,422
+99% +$377K
XOM icon
104
ExxonMobil
XOM
$650B
$908K 0.26%
10,999
+4,710
+75% +$366K
NEE icon
105
NextEra Energy
NEE
$185B
$884K 0.25%
10,441
-2,035
-16% -$163K
SRLN icon
106
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$881K 0.25%
+19,600
New +$885K
FWRD icon
107
Forward Air
FWRD
$461M
$880K 0.25%
9,005
-2
-0% -$211
BIP icon
108
Brookfield Infrastructure Partners
BIP
$19.6B
$877K 0.25%
19,868
+1,856
+10% +$74.9K
UBS icon
109
UBS Group
UBS
$170B
$871K 0.25%
44,380
-268,874
-86% -$5.09M
DHI icon
110
D.R. Horton
DHI
$41.2B
$868K 0.24%
11,645
+1,762
+18% +$153K
VICI icon
111
VICI Properties
VICI
$29.9B
$862K 0.24%
+30,280
New +$849K
SRE icon
112
Sempra
SRE
$58.1B
$856K 0.24%
10,184
-2,442
-19% -$175K
SPGI icon
113
S&P Global
SPGI
$124B
$854K 0.24%
2,081
-481
-19% -$196K
NKE icon
114
Nike
NKE
$64.1B
$840K 0.24%
6,239
+589
+10% +$82.8K
SMG icon
115
ScottsMiracle-Gro
SMG
$4.09B
$833K 0.23%
6,776
-23
-0.3% -$3.22K
KMB icon
116
Kimberly-Clark
KMB
$37.6B
$822K 0.23%
6,671
+1,347
+25% +$178K
VRTX icon
117
Vertex Pharmaceuticals
VRTX
$123B
$811K 0.23%
+3,109
New +$738K
CAT icon
118
Caterpillar
CAT
$361B
$810K 0.23%
3,637
-86
-2% -$18K
WU icon
119
Western Union
WU
$2.53B
$807K 0.23%
+43,080
New +$797K
NOW icon
120
ServiceNow
NOW
$120B
$806K 0.23%
7,235
+475
+7% +$53.2K
EL icon
121
Estee Lauder
EL
$30.4B
$801K 0.23%
2,943
+74
+3% +$22.3K
BMY icon
122
Bristol-Myers Squibb
BMY
$129B
$791K 0.22%
10,833
-11,351
-51% -$762K
PAVE icon
123
Global X US Infrastructure Development ETF
PAVE
$13.5B
$782K 0.22%
27,649
-6,541
-19% -$178K
SO icon
124
Southern Company
SO
$108B
$779K 0.22%
10,744
+2,171
+25% +$147K
EEM icon
125
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$766K 0.22%
+16,965
New +$801K

Similar funds

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $51.7M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.